Literature DB >> 27747459

Complementary Therapies in Inflammatory Bowel Diseases.

Henit Yanai1, Nir Salomon2,3, Adi Lahat2,3.   

Abstract

Inflammatory bowel diseases (IBDs) often take a chronic debilitating course. Given the chronicity of IBD, the limitations of the available medications, their potential side effects, and the impact of the disease on patients' quality of life, it is not surprising IBD patients are ranked among the highest users of complementary and alternative medicine (CAM). Since CAM has become very popular in real-life practice of Western Communities, caregivers must gain more knowledge about these therapies, their mechanism of action, benefits, and risks. This article reviews and discusses up-to-date scientific and clinical data regarding the most prevalent herbal CAM therapies.

Entities:  

Keywords:  CAM; Cannabis; Complementary and alternative medicine; Crohn’s disease; Curcumin; Herbal medicine; Ulcerative colitis

Mesh：

Substances：

Year:  2016        PMID： 27747459     DOI： 10.1007/s11894-016-0537-6

Source DB:  PubMed          Journal:  Curr Gastroenterol Rep        ISSN： 1522-8037


  83 in total

1.  Cannabinoid receptor agonism inhibits transient lower esophageal sphincter relaxations and reflux in dogs.

Authors:  Anders Lehmann; L Ashley Blackshaw; Lena Brändén; Anita Carlsson; Jörgen Jensen; Emelie Nygren; Scott D Smid
Journal:  Gastroenterology       Date:  2002-10       Impact factor: 22.682

2.  Effects of an oral supplementation of germinated barley foodstuff on serum tumour necrosis factor-alpha, interleukin-6 and -8 in patients with ulcerative colitis.

Authors:  Zeinab Faghfoori; Lida Navai; Rahebeh Shakerhosseini; Mohammad Hossein Somi; Zeinab Nikniaz; Mohammad Fahmideh Norouzi
Journal:  Ann Clin Biochem       Date:  2011-03-02       Impact factor: 2.057

Review 3.  Pharmacology of cannabinoid CB1 and CB2 receptors.

Authors:  R G Pertwee
Journal:  Pharmacol Ther       Date:  1997       Impact factor: 12.310

4.  Induction with NCB-02 (curcumin) enema for mild-to-moderate distal ulcerative colitis - a randomized, placebo-controlled, pilot study.

Authors:  Vikas Singla; Venigalla Pratap Mouli; Sushil Kumar Garg; Tarun Rai; Bikash Narayan Choudhury; Prashant Verma; Rachana Deb; Veena Tiwari; Sarika Rohatgi; Rajan Dhingra; Saurabh Kedia; Piyush Kumar Sharma; Govind Makharia; Vineet Ahuja
Journal:  J Crohns Colitis       Date:  2013-09-05       Impact factor: 9.071

5.  Health-related self-perceptions over time and provider-based Complementary and Alternative Medicine (CAM) use in people with inflammatory bowel disease or arthritis.

Authors:  Fuschia M Sirois
Journal:  Complement Ther Med       Date:  2014-07-16       Impact factor: 2.446

6.  Effects of germinated barley foodstuff on microflora and short chain fatty acid production in dextran sulfate sodium-induced colitis in rats.

Authors:  Y Araki; A Andoh; S Koyama; Y Fujiyama; O Kanauchi; T Bamba
Journal:  Biosci Biotechnol Biochem       Date:  2000-09       Impact factor: 2.043

7.  Mechanism for the increased defecation and jejunum mucosal protein content in rats by feeding germinated barley foodstuff.

Authors:  O Kanauchi; K Agata; T Fushiki
Journal:  Biosci Biotechnol Biochem       Date:  1997-03       Impact factor: 2.043

8.  Cannabinoid inhibition of guinea-pig intestinal peristalsis via inhibition of excitatory and activation of inhibitory neural pathways.

Authors:  A Heinemann; A Shahbazian; P Holzer
Journal:  Neuropharmacology       Date:  1999-09       Impact factor: 5.250

Review 9.  Prescribing smoked cannabis for chronic noncancer pain: preliminary recommendations.

Authors:  Meldon Kahan; Anita Srivastava; Sheryl Spithoff; Lisa Bromley
Journal:  Can Fam Physician       Date:  2014-12       Impact factor: 3.275

Review 10.  Acupuncture and moxibustion for inflammatory bowel diseases: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Jun Ji; Yuan Lu; Huirong Liu; Hui Feng; Fuqing Zhang; Luyi Wu; Yunhua Cui; Huangan Wu
Journal:  Evid Based Complement Alternat Med       Date:  2013-09-24       Impact factor: 2.629
View more
  9 in total

Review 1.  Complementary and Alternative Medicine Strategies for Therapeutic Gut Microbiota Modulation in Inflammatory Bowel Disease and their Next-Generation Approaches.

Authors:  Abigail R Basson; Minh Lam; Fabio Cominelli
Journal:  Gastroenterol Clin North Am       Date:  2017-12       Impact factor: 3.806

2.  The Use of Complementary and Alternative Medicine in Patients With Inflammatory Bowel Disease.

Authors:  Steven C Lin; Adam S Cheifetz
Journal:  Gastroenterol Hepatol (N Y)       Date:  2018-07

Review 3.  Pathomechanisms of Oxidative Stress in Inflammatory Bowel Disease and Potential Antioxidant Therapies.

Authors:  Tian Tian; Ziling Wang; Jinhua Zhang
Journal:  Oxid Med Cell Longev       Date:  2017-06-28       Impact factor: 6.543

4.  The Extracts of Morinda officinalis and Its Hairy Roots Attenuate Dextran Sodium Sulfate-Induced Chronic Ulcerative Colitis in Mice by Regulating Inflammation and Lymphocyte Apoptosis.

Authors:  Jian Liang; Jiwang Liang; Hairong Hao; Huan Lin; Peng Wang; Yanfang Wu; Xiaoli Jiang; Chaodi Fu; Qian Li; Ping Ding; Huazhen Liu; Qingping Xiong; Xiaoping Lai; Lian Zhou; Shamyuen Chan; Shaozhen Hou
Journal:  Front Immunol       Date:  2017-08-02       Impact factor: 7.561

5.  Toxicity Study of 28-Day Subcutaneous Injection of Arctigenin in Beagle Dogs.

Authors:  Jie Li; Yun-Gang Lv; Li-Hong Pan; Fang-Fang Yao; Tao Peng; Yu-Jun Tan; Gui-Min Zhang; Zhong Liu; Jing-Chun Yao; Yu-Shan Ren
Journal:  Front Pharmacol       Date:  2019-10-16       Impact factor: 5.810

Review 6.  New insights into the interplay between autophagy, gut microbiota and inflammatory responses in IBD.

Authors:  Anaïs Larabi; Nicolas Barnich; Hang Thi Thu Nguyen
Journal:  Autophagy       Date:  2019-07-09       Impact factor: 16.016

7.  Intestinal CD11b+ B Cells Ameliorate Colitis by Secreting Immunoglobulin A.

Authors:  Ying Fu; Zhiming Wang; Baichao Yu; Yuli Lin; Enyu Huang; Ronghua Liu; Chujun Zhao; Mingfang Lu; Wei Xu; Hongchun Liu; Yongzhong Liu; Luman Wang; Yiwei Chu
Journal:  Front Immunol       Date:  2021-11-03       Impact factor: 7.561

8.  Trends in inflammatory bowel disease treatment in the past two decades-a high-level text mining analysis of PubMed publications.

Authors:  Eyal Klang; Yiftach Barash; Shelly Soffer; Eyal Shachar; Adi Lahat
Journal:  United European Gastroenterol J       Date:  2021-08-25       Impact factor: 4.623

Review 9.  Cannabis and Canabidinoids on the Inflammatory Bowel Diseases: Going Beyond Misuse.

Authors:  Antonelly Cassio Alves de Carvalho; Gabriela Achete de Souza; Samylla Vaz de Marqui; Élen Landgraf Guiguer; Adriano Cressoni Araújo; Claudio José Rubira; Ricardo de Alvares Goulart; Uri Adrian Prync Flato; Patricia Cincotto Dos Santos Bueno; Rogério Leone Buchaim; Sandra M Barbalho
Journal:  Int J Mol Sci       Date:  2020-04-22       Impact factor: 5.923
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.